Jacobs & Co’s Colgate-Palmolive CL Stock Holding History

Jacobs & Co’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Sell	4,815 -2,683	-36%	-$235K	0.04%	98
2026 Q1	$639K	Hold	7,498	–	–	0.06%	91
2025 Q4	$592K	Buy	7,498 +60	+0.8%	+$4.7K	0.06%	94
2025 Q3	$594K	Sell	7,438 -500	-6%	-$42.7K	0.06%	94
2025 Q2	$721K	Hold	7,938	–	–	0.07%	90
2025 Q1	$743K	Hold	7,938	–	–	0.08%	89
2024 Q4	$721K	Hold	7,938	–	–	0.07%	90
2024 Q3	$824K	Hold	7,938	–	–	0.08%	90
2024 Q2	$770K	Hold	7,938	–	–	0.08%	92
2024 Q1	$714K	Hold	7,938	–	–	0.08%	92
2023 Q4	$632K	Sell	7,938 -125	-2%	-$9.4K	0.07%	92
2023 Q3	$573K	Sell	8,063 -125	-2%	-$9.35K	0.07%	93
2023 Q2	$630K	Sell	8,188 -13	-0.2%	-$1.01K	0.07%	93
2023 Q1	$616K	Sell	8,201 -1,004	-11%	-$74.7K	0.08%	94
2022 Q4	$725K	Buy	9,205 +592	+7%	+$44.4K	0.09%	92
2022 Q3	$605K	Hold	8,613	–	–	0.09%	92
2022 Q2	$690K	Hold	8,613	–	–	0.09%	89
2022 Q1	$653K	Hold	8,613	–	–	0.07%	90
2021 Q4	$735K	Hold	8,613	–	–	0.08%	91
2021 Q3	$650K	Hold	8,613	–	–	0.07%	89
2021 Q2	$700K	Hold	8,613	–	–	0.08%	90
2021 Q1	$678K	Hold	8,613	–	–	0.08%	89
2020 Q4	$736K	Hold	8,613	–	–	0.1%	86
2020 Q3	$664K	Sell	8,613 -133	-2%	-$10.1K	0.1%	85
2020 Q2	$640K	Sell	8,746 -90	-1%	-$6.39K	0.1%	87
2020 Q1	$586K	Sell	8,836 -55	-0.6%	-$3.88K	0.11%	89
2019 Q4	$612K	Hold	8,891	–	–	0.09%	92
2019 Q3	$653K	Hold	8,891	–	–	0.11%	92
2019 Q2	$637K	Sell	8,891 -75	-0.8%	-$5.32K	0.1%	96
2019 Q1	$614K	Sell	8,966 -800	-8%	-$51.7K	0.1%	100
2018 Q4	$581K	Sell	9,766 -300	-3%	-$18.8K	0.11%	91
2018 Q3	$673K	Sell	10,066 -1,300	-11%	-$86.6K	0.11%	91
2018 Q2	$736K	Sell	11,366 -346	-3%	-$22.6K	0.13%	90
2018 Q1	$839K	Hold	11,712	–	–	0.16%	90
2017 Q4	$883K	Hold	11,712	–	–	0.16%	92
2017 Q3	$853K	Hold	11,712	–	–	0.16%	93
2017 Q2	$868K	Hold	11,712	–	–	0.17%	92
2017 Q1	$857K	Sell	11,712 -250	-2%	-$17.5K	0.18%	91
2016 Q4	$782K	Sell	11,962 -300	-2%	-$20.6K	0.17%	94
2016 Q3	$909K	Sell	12,262 -495	-4%	-$36.6K	0.2%	89
2016 Q2	$933K	Sell	12,757 -450	-3%	-$32K	0.22%	89
2016 Q1	$933K	Sell	13,207 -250	-2%	-$16.6K	0.22%	91
2015 Q4	$852K	Sell	13,457 -150	-1%	-$9.98K	0.22%	94
2015 Q3	$863K	Sell	13,607 -125	-0.9%	-$8.17K	0.23%	95
2015 Q2	$898K	Sell	13,732 -450	-3%	-$30.5K	0.22%	98
2015 Q1	$983K	Buy	14,182 +350	+3%	+$24.2K	0.25%	92
2014 Q4	$957K	Hold	13,832	–	–	0.25%	92
2014 Q3	$902K	Sell	13,832 -300	-2%	-$19.8K	0.26%	94
2014 Q2	$964K	Sell	14,132 -200	-1%	-$13.4K	0.28%	87
2014 Q1	$930K	Sell	14,332 -675	-4%	-$42.5K	0.29%	88
2013 Q4	$978K	Sell	15,007 -725	-5%	-$46.4K	0.31%	83
2013 Q3	$932K	Sell	15,732 -1,020	-6%	-$60.4K	0.32%	80
2013 Q2	$959K	Buy	+16,752	New	+$994K	0.35%	80

Other funds holding CL

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

PAM

PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Jacobs & Co's CL Position: Q2 2026 in Review

Jacobs & Co reduced its Colgate-Palmolive (CL) stake by 36% in Q2 2026, selling an estimated $235K and leaving 4,815 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #98.

Jacobs & Co first reported a position in CL in Q2 2013 and has held it in 53 quarters since. The position peaked at $983K in Q1 2015. 895 funds tracked by Wall St. Rank hold CL as of Q2 2026.

Jacobs & Co held 4,815 shares of Colgate-Palmolive worth $441K as of Q2 2026.
Jacobs & Co sold 2,683 Colgate-Palmolive shares in Q2 2026, an estimated $235K.
Colgate-Palmolive made up 0.04% of Jacobs & Co's portfolio in Q2 2026, its #98 holding.
Jacobs & Co first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 53 quarters since.
Jacobs & Co's Colgate-Palmolive position peaked at $983K in Q1 2015.
895 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Jacobs & Co's 13F filing for Q2 2026, filed 9 Jul 2026.